The five records in this collection are premarket notification filings decided between September 1 and October 29, 2026, each carrying the decision code SESE, which the FDA records describe as Substantially Equivalent. Three were reviewed under the Special clearance type and two under Traditional. The applicant address on every record is in Naples, Florida, and the orthopedic advisory committee appears on four of the five. The collection is a snapshot of these filings, not a measure of company sales, total portfolio or safety performance. [1][2][3][4][5]

Bone fixation and soft-tissue hardware

K263602 covers Arthrex Plates, Screws and Pins, and Washers under product code HRS, with a decision date of October 29, 2026 and a Special clearance type. K263477 covers the Arthrex FiberButton under product code MBI, decided October 27, 2026, also Special. Innolitics lists the FiberButton under 21 CFR 888.3040 and records that the FDA found the device substantially equivalent to marketed primary and additional predicate devices. [1][2][9]

K262451 covers Arthrex DynaNite Staples under product code JDR, decided September 1, 2026 under the Traditional clearance type. Arthrex's published foot and ankle pages list DynaNite Nitinol Compression Plates among its metal plate offerings and describe a complement of metal plates with cortical, cancellous and locking screws for indications including fibular fractures, deltoid avulsion, and forefoot and midfoot fusion. [5][7][10]

Spine and beaming submissions

K262618 covers the Arthrex Spine Compression FT Screw under product code MRW, decided September 24, 2026 under the Traditional clearance type. The record lists the device name as a facet screw spinal device, shows a device class of U and no regulation number, and carries an unknown advisory committee description while naming the orthopedic committee for review. [4]

K262975 covers the Arthrex Beaming System under product code HWC, decided September 25, 2026 under the Special clearance type. The record's device name is listed as a bone fixation screw and its regulation number as 888.3040. The filing does not state which anatomical sites the system addresses. [3]

Applicant identity and published company description

Arthrex, Inc. is the applicant named on all five records, each listing 1370 Creekside Blvd., Naples, FL, as the filing address. That address is a filing detail and is not presented here as a verified headquarters. The records do not identify a parent company or brand owner beyond the applicant name. [1][2][3][4][5]

Arthrex's own About Us page describes the company as a global medical device company and leader in multispecialty minimally invasive surgical technology innovation, scientific research, manufacturing quality and medical education, with a mission of Helping Surgeons Treat Their Patients Better. The same page states that Arthrex has agency and lab locations throughout the US and subsidiaries and distributors in more than 80 countries. These are the manufacturer's published statements. [8]

How to read the collection

The collection contains five linked 510(k) records, all with a SESE decision, and the record sample contains the same five entries, so the sample and collection counts match here. No recall records appear in the sample. The dates, product codes and clearance types above come from the individual FDA records; the collection does not establish total company clearances, commercial availability of any device, or clinical performance. [1][2][3][4][5]